Publisher
Springer Nature Singapore
Reference68 articles.
1. Wygnanski-Jaffe T, Levin AV. Introductory genetics for the ophthalmologist. American Academy of Ophthalmology, Focal Points. Clin Module Ophthalmol. 2005;23:1–11.
2. Sadagopan KA, Capasso J, Levin AV. Genetics for the ophthalmologist. Oman J Ophthalmol. 2012;5(3):144–9.
3. Campbell JP, McFarland TJ, Stout JT. Ocular Gene Therapy. Dev Ophthalmol. 2016;55:317–21.
4. ClinicalTrials.gov. 2022. https://clinicaltrials.gov/ct2/results?-cond=Eye+Diseases&term=gene+therapy&cntry=&state=&city=&dist=.
5. Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390(10097):849–60.